KRAS Blockers Shrank Nerve Tumors in Mice and Could Become an Alternative to Current NF1 Drugs

Cincinnati Children’s researchers report KRAS inhibitors matched MEK inhibitors in shrinking NF1 nerve tumors in mice. Human trials have not started.

Have A Referral?